An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-18

Study Completion Date

2024-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals

NCT05224804

Adverse Drug Reaction

COMPLETED

Perceptions of Healthcare Professionals Toward Clinical Pharmacy Practice in Egypt

NCT07248150

Perception of Clinical Pharmacy Practice

COMPLETED

Antibiotic Abuse Patterns in Gharbia, Egypt

NCT06503055

Antibiotic Abuse

RECRUITING

Educational Intervention in Pharmacovigilance for Hospital Health Professionals

NCT02134587

Adverse Drug Reaction

COMPLETED NA

The Role of Clinical Pharmacist in Monitoring Drug Therapy in the Cardiovascular and Coronary Care Units in Libya.

NCT05531552

Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Reaction Drug Hypersensitivity Drug Abuse Drug Interaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

questionner

three sections questioner including: demographics, reported cases, unreported cases

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all health care providers are invited to share in the study
* minimum experience required is one year in health carrier.
* accept sharing in the study